The Gross Law Firm notifies investors that a class action has commenced in the United States District Court for the District of Connecticut on behalf of shareholders of GeneDx Holdings Corp. who purchased Common stock between April 16, 2025 and May 4, 2026.
According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that: Throughout the class period, WGS repeatedly made statements that would have caused the average investor to believe that the Fabric acquisition would improve the Company’s financials and create efficiencies between it and the Company’s core business. These statements include such statements such as: “There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric as we lean into the best possible algorithms to optimize dry lab processes.” These and similar statements made throughout the Class Period were false. In truth, defendants knew of, or recklessly disregarded, significant problems in Fabric’s viability that would negatively impact WGS’s overall business and operations. As a result, the Company’s statements concerning its business, operations, and prospects lacked a reasonable factual basis, and shares of WGS common stock traded at artificially inflated prices during the Class Period.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until August 3, 2026 to request that the court appoint them lead plaintiff.
To receive more information, please fill out the form.
